Market Overview:
Theophylline is a drug used in the treatment of asthma, bronchitis, emphysema and other respiratory diseases. It is also used to treat heart failure and insomnia. Theophylline is available as an injection, tablet or capsule. The global theophylline market was valued at ,023 million in 2017 and is projected to reach ,521 million by 2030 at a CAGR of 5.2%. Growth in the market will be driven by increasing prevalence of respiratory diseases and rising demand for better treatment options.
Product Definition:
A bronchodilator used to treat asthma and other respiratory conditions. It relaxes the muscles around the airways, making it easier to breathe.
Injection:
Injection is a process through which the active ingredients of a drug are mixed with solvents and then injected into the patient's body. In most cases, injections are used to administer drugs that would not be suitable for oral consumption. The most common types of injectable drugs include insulin, hormones, anesthetics & sedatives and anti-inflammatory agents among others.
Tablet:
A tablet is a pharmaceutical dosage form that contains an amount of drug substance usually for oral administration. The drug substances can be in the form of powder or solution and are dissolved in inert carriers like solvents, oils, or water before being administered to the patient.
The tablets are available as both generic as well as branded forms depending upon the availability of ingredients and current market demand.
Application Insights:
The asthma segment dominated the global market in 2017 and is expected to witness significant growth over the forecast period. Theophylline is used for the treatment of asthma due to its bronchodilating properties. It reduces inflammation and improves airflow through constrictionless relaxation of muscles in lungs, resulting in lessening of attacks by patients suffering from asthma.
The other application segment includes cardiovascular diseases, gastrointestinal disorders, nervous system disorders, skin diseases and urinary tract infections among others. Other applications are anticipated to witness significant growth over the forecast period owing to increasing use as a dietary supplement for various health problems including sleeplessness, irritability and anxiety among children; heartburn; indigestion; gas; nausea or vomiting caused by pregnancy or food poisoning etc., observed across various regions globally.
Regional Analysis:
Asia Pacific was the largest market in 2017 and is expected to maintain its position during the forecast years. The presence of a large target population, availability of generic version of all major brands, high awareness about available treatment options along with favorable government initiatives for asthma & COPD management are some factors responsible for this growth. China accounted for approximately 50% share in Asia Pacific market due to presence of a large number of companies manufacturing generic versions as well as brand-name products.
In addition, increasing prevalence rate coupled with growing disposable income will boost demand further over the forecast period.
Europe was estimated at USD X billion in 2017.
Growth Factors:
- Increasing prevalence of respiratory diseases: The incidence of respiratory diseases is increasing globally due to the changing lifestyle and environmental factors. This is expected to drive the demand for theophylline in the coming years.
- Growing awareness about asthma and its treatment: There is a growing awareness among people about asthma and its treatment options, which is likely to boost the demand for theophylline in near future.
- Rising number of smokers: The number of smokers across the globe continues to rise, leading to an increase in cases of chronic obstructive pulmonary disease (COPD). This will create a high demand fortheophyllinein order to treat COPD patients.
- Technological advancements in drug delivery systems: Drug delivery systems are evolving rapidly with new technologies being developed regularly. This is likelyto provide opportunities for growthfortheophyllinemarket playersin terms of product innovation and development .
Scope Of The Report
Report Attributes
Report Details
Report Title
Theophylline Market Research Report
By Type
Injection, Tablet, Capsule
By Application
Asthma, Insomnia, Other
By Companies
Pfizer, Mylan, Aarti Drugs, Biotechnica Pharma Global, Teva Pharmaceuticals, Zim, Teva Pharmaceuticals, Astellas Pharma, AdvaCarePharma, Aldo-Union
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Theophylline Market Report Segments:
The global Theophylline market is segmented on the basis of:
Types
Injection, Tablet, Capsule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Asthma, Insomnia, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Mylan
- Aarti Drugs
- Biotechnica Pharma Global
- Teva Pharmaceuticals
- Zim
- Teva Pharmaceuticals
- Astellas Pharma
- AdvaCarePharma
- Aldo-Union
Highlights of The Theophylline Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Tablet
- Capsule
- By Application:
- Asthma
- Insomnia
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Theophylline Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Theophylline is a medication used to treat asthma. It works by relaxing the airways and reducing inflammation.
Some of the key players operating in the theophylline market are Pfizer, Mylan, Aarti Drugs, Biotechnica Pharma Global, Teva Pharmaceuticals, Zim, Teva Pharmaceuticals, Astellas Pharma, AdvaCarePharma, Aldo-Union.
The theophylline market is expected to register a CAGR of 5.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Theophylline Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Theophylline Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Theophylline Market - Supply Chain
4.5. Global Theophylline Market Forecast
4.5.1. Theophylline Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Theophylline Market Size (000 Units) and Y-o-Y Growth
4.5.3. Theophylline Market Absolute $ Opportunity
5. Global Theophylline Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Theophylline Market Size and Volume Forecast by Type
5.3.1. Injection
5.3.2. Tablet
5.3.3. Capsule
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Theophylline Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Theophylline Market Size and Volume Forecast by Application
6.3.1. Asthma
6.3.2. Insomnia
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Theophylline Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Theophylline Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Theophylline Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Theophylline Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Theophylline Demand Share Forecast, 2019-2026
9. North America Theophylline Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Theophylline Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Theophylline Market Size and Volume Forecast by Application
9.4.1. Asthma
9.4.2. Insomnia
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Theophylline Market Size and Volume Forecast by Type
9.7.1. Injection
9.7.2. Tablet
9.7.3. Capsule
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Theophylline Demand Share Forecast, 2019-2026
10. Latin America Theophylline Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Theophylline Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Theophylline Market Size and Volume Forecast by Application
10.4.1. Asthma
10.4.2. Insomnia
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Theophylline Market Size and Volume Forecast by Type
10.7.1. Injection
10.7.2. Tablet
10.7.3. Capsule
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Theophylline Demand Share Forecast, 2019-2026
11. Europe Theophylline Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Theophylline Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Theophylline Market Size and Volume Forecast by Application
11.4.1. Asthma
11.4.2. Insomnia
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Theophylline Market Size and Volume Forecast by Type
11.7.1. Injection
11.7.2. Tablet
11.7.3. Capsule
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Theophylline Demand Share, 2019-2026
12. Asia Pacific Theophylline Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Theophylline Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Theophylline Market Size and Volume Forecast by Application
12.4.1. Asthma
12.4.2. Insomnia
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Theophylline Market Size and Volume Forecast by Type
12.7.1. Injection
12.7.2. Tablet
12.7.3. Capsule
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Theophylline Demand Share, 2019-2026
13. Middle East & Africa Theophylline Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Theophylline Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Theophylline Market Size and Volume Forecast by Application
13.4.1. Asthma
13.4.2. Insomnia
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Theophylline Market Size and Volume Forecast by Type
13.7.1. Injection
13.7.2. Tablet
13.7.3. Capsule
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Theophylline Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Theophylline Market: Market Share Analysis
14.2. Theophylline Distributors and Customers
14.3. Theophylline Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mylan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Aarti Drugs
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biotechnica Pharma Global
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Teva Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Zim
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teva Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Astellas Pharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. AdvaCarePharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Aldo-Union
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
